Clinical Trial: RCT of NLP-Based Feedback for Improving SDM in Men with Localized Prostate Cancer

U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06856694) titled 'RCT of NLP-Based Feedback for Improving SDM in Men with Localized Prostate Cancer' on Feb. 14.

Brief Summary: The purpose of the research is to assess the impact of a natural language processing + artificial intelligence (NLP+AI)-based risk communication feedback system to improve quality of risk communication of key tradeoffs during prostate cancer consultations among physicians and to improve patient decision making. In this cluster randomized trial, an evaluable 220 patients with newly diagnosed clinically localized prostate cancer will be cluster randomized within an evaluable 22 physicians to:

1. a control arm, in which patien...